← Back
$GALT All transactions

GALECTIN THERAPEUTICS INC

M 10b5-1 Plan

$ Value

$0

Shares

7,829

Price

$0

Filed

Dec 19

Insider

Name

LEWIS JOEL

Title

President and CEO

CIK

0001725595

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-17

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,171

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025. | The options vested 100% on December 31, 2020. | These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose. | The shares were sold in multiple transactions at prices ranging from $7.00 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Filing Info

Accession No.

0001133416-25-000071

Form Type

4

Issuer CIK

0001133416

LEWIS JOEL's History

Date Ticker Type Value
2026-01-16 GALT A $0
2026-01-16 GALT A $0
2026-01-16 GALT A $0
2026-01-06 GALT $135K
2026-01-05 GALT $108K
2026-01-05 GALT $219K
2026-01-02 GALT M $0
2026-01-02 GALT $78K
2026-01-02 GALT M $0
2025-12-17 GALT M $22K

Other Insiders at GALT (90d)

Insider Bought Sold Last
ELDRED KARY $810 2026-02-06
Brem Henry 2026-03-12